// App-Quantinova.ai

Abstract 11430 : Etripamil Nasal Spray Reduces Heart Rate in Patients with Paroxysmal Supraventricular Tachycardia Prior to Conversion to Sinus Rhythm

Researchers

Presenter

  • James E Ip

Principal Investigators

  • Bruce S Stambler

  • Philip T Sager

  • Silvia Shardonofsky

  • Benoit Coutu

  • A Shekhar Pandey

  • Blandine Mondesrt

  • Atul Verma

  • Francis Plat

  • Michael Chen

  • Alan J Camm

Medical Centers

  • Weill Cornell Medicine, New York, NY

  • SAGER CONSULTING EXPERTS, San Francisco, CA

  • TCM Groups Inc., NJ

  • Partners in Advance Cardiac Evaluation, Newmarket, Canada

  • MILESTONE PHARMACEUTICALS, Montreal, Canada

  • Milestone Pharmaceuticals,Montreal St Laurent, QC, Canada

  • St George's, University of London, London, United Kingdom

  • PIEDMONT HEART INST, Atlanta, GA

  • CHUM Hotel Dieu Montreal, Montreal, Canada

  • Medecine, Montreal Heart Institute, Montreal, Canada

  • Cambridge Cardiac Care Centre, Cambridge, Canada

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Etripamil

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved